COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 174 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,526 | -26.8% | 9,330 | -29.6% | 0.00% | – |
| Q2 2023 | $284,678 | -53.4% | 13,247 | -47.9% | 0.00% | – |
| Q1 2023 | $610,258 | +182.8% | 25,438 | +173.5% | 0.00% | – |
| Q4 2022 | $215,760 | +26.2% | 9,300 | -13.0% | 0.00% | – |
| Q3 2022 | $171,000 | -69.8% | 10,684 | -66.5% | 0.00% | – |
| Q2 2022 | $566,000 | +3.3% | 31,900 | +18.6% | 0.00% | – |
| Q1 2022 | $548,000 | -14.9% | 26,900 | -21.9% | 0.00% | – |
| Q4 2021 | $644,000 | +107.7% | 34,434 | +119.3% | 0.00% | – |
| Q3 2021 | $310,000 | +34.8% | 15,700 | +61.3% | 0.00% | – |
| Q2 2021 | $230,000 | -89.9% | 9,734 | -89.9% | 0.00% | – |
| Q1 2021 | $2,280,000 | -71.5% | 96,200 | -75.9% | 0.00% | – |
| Q4 2020 | $7,996,000 | +268.3% | 399,212 | +282.8% | 0.00% | – |
| Q3 2020 | $2,171,000 | +121.5% | 104,300 | +86.2% | 0.00% | – |
| Q2 2020 | $980,000 | -58.0% | 56,007 | -60.9% | 0.00% | – |
| Q1 2020 | $2,336,000 | +61.9% | 143,111 | +104.2% | 0.00% | – |
| Q4 2019 | $1,443,000 | +138.1% | 70,100 | +32.9% | 0.00% | – |
| Q3 2019 | $606,000 | -82.7% | 52,751 | -80.2% | 0.00% | – |
| Q2 2019 | $3,498,000 | +496.9% | 265,984 | +587.3% | 0.00% | – |
| Q1 2019 | $586,000 | -48.1% | 38,700 | -41.2% | 0.00% | – |
| Q4 2018 | $1,129,000 | -38.8% | 65,800 | -47.4% | 0.00% | – |
| Q3 2018 | $1,845,000 | -48.3% | 125,200 | -16.3% | 0.00% | -100.0% |
| Q2 2018 | $3,569,000 | +72.4% | 149,659 | +84.7% | 0.00% | 0.0% |
| Q1 2018 | $2,070,000 | -10.6% | 81,018 | -35.4% | 0.00% | – |
| Q4 2017 | $2,315,000 | +353.0% | 125,377 | +157.1% | 0.00% | – |
| Q3 2017 | $511,000 | +209.7% | 48,763 | +269.4% | 0.00% | – |
| Q2 2017 | $165,000 | -59.8% | 13,200 | -67.6% | 0.00% | – |
| Q1 2017 | $410,000 | -31.7% | 40,800 | +5.9% | 0.00% | – |
| Q4 2016 | $600,000 | +198.5% | 38,530 | +324.0% | 0.00% | – |
| Q3 2015 | $201,000 | – | 9,087 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |